• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯疱疹性角膜炎角膜移植后的复发率和排斥率。

Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis.

作者信息

Lomholt J A, Baggesen K, Ehlers N

机构信息

Department of Ophthalmology, Arhus University Hospital, Denmark.

出版信息

Acta Ophthalmol Scand. 1995 Feb;73(1):29-32. doi: 10.1111/j.1600-0420.1995.tb00008.x.

DOI:10.1111/j.1600-0420.1995.tb00008.x
PMID:7627755
Abstract

Seventy-two penetrating primary keratoplasties for herpes simplex keratitis performed from 1970 to 1993 were reviewed. Postoperative follow-up periods ranged from 6 months to 16 years with 2 years median. Epithelial herpetic recurrence occurred in 25% of the transplants the first year and in 44% during the first 2 years. Primary allograft rejection was observed in 29% of the grafts the first year and in 46% during the first 2 years. Preoperative inflammation was a risk factor for preservation of a clear cornea (p < 0.10). The degree of corneal vascularization prior to operation did not influence the survival of the grafts. The overall one-year survival rate of a clear graft was 84% and the 2-year survival rate was 67%. Prophylactic antiviral treatment is discussed.

摘要

回顾了1970年至1993年期间为单纯疱疹性角膜炎施行的72例穿透性原发性角膜移植术。术后随访时间为6个月至16年,中位数为2年。移植后的第一年,25%的患者出现上皮性疱疹复发,前两年复发率为44%。第一年29%的移植物发生原发性同种异体移植排斥反应,前两年为46%。术前炎症是角膜保持透明的一个危险因素(p<0.10)。术前角膜血管化程度不影响移植物的存活。透明移植物的总体一年存活率为84%,两年存活率为67%。文中还讨论了预防性抗病毒治疗。

相似文献

1
Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis.单纯疱疹性角膜炎角膜移植后的复发率和排斥率。
Acta Ophthalmol Scand. 1995 Feb;73(1):29-32. doi: 10.1111/j.1600-0420.1995.tb00008.x.
2
Recurrent herpetic keratitis in penetrating keratoplasty.穿透性角膜移植术中复发性疱疹性角膜炎
Doc Ophthalmol. 1995;90(1):29-33. doi: 10.1007/BF01203291.
3
Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis.单纯疱疹性角膜炎穿透性角膜移植术后的抗病毒治疗。
Arch Ophthalmol. 1994 May;112(5):601-7. doi: 10.1001/archopht.1994.01090170045020.
4
Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure.单纯疱疹病毒性角膜炎:组织病理学新生血管形成和角膜移植失败。
Cornea. 2009 Oct;28(9):963-5. doi: 10.1097/ICO.0b013e31819c4e55.
5
Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.全板层深板层角膜移植与穿透性角膜移植治疗单纯疱疹病毒性角膜炎所致角膜白斑的长期比较。
Am J Ophthalmol. 2012 Feb;153(2):291-299.e2. doi: 10.1016/j.ajo.2011.07.020. Epub 2011 Oct 13.
6
Polymerase chain reaction detection of herpes simplex virus in tear fluid from atypical herpetic epithelial keratitis after penetrating keratoplasty.穿透性角膜移植术后非典型疱疹性上皮性角膜炎患者泪液中单纯疱疹病毒的聚合酶链反应检测
Am J Ophthalmol. 1996 Nov;122(5):732-5. doi: 10.1016/s0002-9394(14)70497-0.
7
HSV keratitis: histopathologic predictors of corneal allograft complications.单纯疱疹病毒性角膜炎:角膜移植并发症的组织病理学预测指标
Trans Am Ophthalmol Soc. 2008;106:161-68; discussion 168-70.
8
Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.角膜移植术后疱疹性角膜炎的免疫抑制疗效。
Cornea. 2011 Dec;30(12):1398-405. doi: 10.1097/ICO.0b013e31821e65b3.
9
Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis.全身性阿昔洛韦与穿透性角膜移植术治疗单纯疱疹性角膜炎
Doc Ophthalmol. 1992;80(4):363-9. doi: 10.1007/BF00154385.
10
Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.穿透性角膜移植术后口服小剂量长期阿昔洛韦治疗单纯疱疹性角膜炎的疗效
Ocul Immunol Inflamm. 1999 Mar;7(1):51-60. doi: 10.1076/ocii.7.1.51.8113.

引用本文的文献

1
Outcomes of Corneal Transplantation for Herpetic Keratitis: A Narrative Review.疱疹性角膜炎角膜移植的结果:叙述性综述。
Viruses. 2024 Aug 31;16(9):1403. doi: 10.3390/v16091403.
2
In vivo CRISPR gene editing in patients with herpetic stromal keratitis.体内 CRISPR 基因编辑治疗疱疹性基质性角膜炎。
Mol Ther. 2023 Nov 1;31(11):3163-3175. doi: 10.1016/j.ymthe.2023.08.021. Epub 2023 Aug 31.
3
Meganuclease targeting HSV-1 protects against herpetic keratitis: Application to corneal transplants.靶向单纯疱疹病毒1型的归巢核酸酶可预防疱疹性角膜炎:在角膜移植中的应用。
Mol Ther Nucleic Acids. 2022 Nov 9;30:511-521. doi: 10.1016/j.omtn.2022.11.006. eCollection 2022 Dec 13.
4
Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes.角膜移植术后感染性角膜炎:流行病学、危险因素、管理及预后
Front Med (Lausanne). 2021 Jul 7;8:707242. doi: 10.3389/fmed.2021.707242. eCollection 2021.
5
Recurrence of herpes simplex virus endotheliitis in a Descemet membrane endothelial keratoplasty graft: mimicking fungal interface infection.Descemet膜内皮角膜移植术中单纯疱疹病毒内皮炎复发:酷似真菌性界面感染
BMJ Case Rep. 2019 May 6;12(5):e229441. doi: 10.1136/bcr-2019-229441.
6
Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty.低剂量全身环孢素治疗高危穿透性角膜移植术的不良反应
Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1111-9. doi: 10.1007/s00417-015-3008-0. Epub 2015 Apr 21.
7
Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis.深层前板层角膜移植治疗活动性或静止性单纯疱疹性基质角膜炎的疗效。
Graefes Arch Clin Exp Ophthalmol. 2012 Aug;250(8):1187-94. doi: 10.1007/s00417-012-1947-2. Epub 2012 Feb 17.
8
Antiviral treatment following penetrating keratoplasty for herpetic keratitis.疱疹性角膜炎行穿透性角膜移植术后的抗病毒治疗。
Eye (Lond). 2011 Apr;25(4):470-4. doi: 10.1038/eye.2010.237. Epub 2011 Jan 28.
9
Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.核酸酶介导的抑制单纯疱疹病毒 1 感染培养细胞。
Mol Ther. 2011 Apr;19(4):694-702. doi: 10.1038/mt.2010.302. Epub 2011 Jan 11.
10
Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure.单纯疱疹病毒性角膜炎:组织病理学新生血管形成和角膜移植失败。
Cornea. 2009 Oct;28(9):963-5. doi: 10.1097/ICO.0b013e31819c4e55.